[Pubmed] The tale and trials of Efgartigimod: A newly FDA approved drug for the treatment of Myasthenia gravis
Posté : 04 avr. 2023 12:00
J Pak Med Assoc. 2022 Nov;72(11):2366-2367.
NO ABSTRACT
PMID:37013332
Source: https://pubmed.ncbi.nlm.nih.gov/3701333 ... t6+86293ac